"I love Global Biopharmaceutical Company - Bristol Myers Squibb"

2022-05-04 11:41:03

Our Medicines Contact Us Careers United States Close Icon AmericasArgentinaSpanishBrazilPortuguese CanadaEnglish FrenchChileSpanishColombiaSpanishMexicoSpanishPeruSpanishUnited StatesEnglishVenezuelaSpanishAsia PacificAustraliaEnglishChinaSimplified ChineseIndiaEnglishJapanJapaneseKoreaKoreanNew ZealandEnglishTaiwanTraditional ChineseEuropeAustriaGermanBelgiumEnglish DutchFrenchCzech RepublicEnglishDenmarkDanishFinlandFinnishFrance FrenchGermanyGermanGreeceGreekHungaryHungarianIrelandEnglishItalyItalianLuxembourgEnglishNetherlandsDutchNorwayNorwegianPolandPolishPortugalEnglishRomaniaRomanianRussiaRussianSpainSpanishSwedenSwedishSwitzerlandGerman FrenchUnited KingdomEnglishMiddle EastSaudi ArabiaEnglish ArabicTurkeyTurkishUnited Arab EmiratesEnglish ArabicOtherOther MarketsDistributor Markets Previous Page Icon Previous Page Icon Our Medicines Patients & Caregivers Next Page Icon Our medicines Get help paying for your medicine Patient resources Next Page Icon Immunology Patient Resources Risk Evaluation and Mitigation Strategies (REMS) FEATUREDGet Help Paying For Your Medicine> Healthcare Providers Next Page Icon Pre-Approval Access to Investigational Medicines Next Page Icon Investigational drugs available 340B Distribution Practice Fact Sheet FEATUREDAnnual Report 2021> Researchers Next Page Icon Areas of Focus Next Page Icon Our research in Immunology In the pipeline Our R&D Team Next Page Icon Researcher bios Research Publications "Golden Ticket" Contests Translational Medicine Clinical Trials & Research Next Page Icon Disclosure Commitment Independent Research Next Page Icon Investigator Sponsored Research Portal Areas of Interest & Competitive Research Grants Compound & Technology Requests Data Sharing Request Process The Thomas O. Daniel Research Incubator and Collaboration Center Next Page Icon About Incubator and Collaboration Center Application Process and Criteria Frequently Asked Questions Contact Us FEATUREDArea of Focus> Investors Next Page Icon Stock information Next Page Icon Dividend history Stock split history Investment return calculator Financial reporting Next Page Icon SEC filings Quarterly Results Product Sales summary Annual Reports Analyst coverage Events and presentations Shareholder Services Next Page Icon Annual Meeting of Shareholders Cost Basis calculator Acquisition FAQs for Celgene Shareholders Acquisition-related information for Celgene shareholders Next Page Icon Tax Implications of Celgene Acquisition Acquisition FAQs for Celgene Shareholders Investor contacts Next Page Icon Investor Alerts Subscribe Investor Alerts Unsubscribe RSS feeds FEATUREDAnnual Report 2021> Business Development Next Page Icon Our Partnerships Why Partner With Us Areas of Interest Business Development Leadership Team Begin a Discussion Global Alliances leadership team FEATUREDDiversity and Inclusion Report> News Next Page Icon Press Releases Next Page Icon RSS Feeds Unsubscribe to News Email Alerts - Bristol Myers Squibb Subscribe to New Email Alerts - Bristol Myers Squibb Life & Science Stories Next Page Icon All People Science News & Perspectives Life & Science Stories Alert Subscription Life & Science Stories Alerts Unsubscribe Medical Meetings Next Page Icon BMS at ACTRIMS Forum 2022 BMS at ECCO 2022 BMS at AHA Scientific Sessions 2021 BMS at ASH 2021 BMS at ACR Convergence 2021 BMS at ACG 2021 Annual Meeting BMS at ECTRIMS 2021 BMS at EADV 2021 BMS at EULAR 2021 Congress BMS at ASCO and EHA 2021 Media Library Next Page Icon Scientific Media Resources Disease State Infographics Media Contacts FEATUREDAnnual Report 2021> About Us Next Page Icon Our company Next Page Icon Our Mission, Vision, Values & Commitment Our principles History Timeline Survivorship Today Committed to creating a better future for cancer patients Global Patient Week Patient & employee stories Governance Doing business with us as a supplier Achievements Worldwide Locations Corporate Brand Leadership Next Page Icon Leadership Team Board of Directors People & Business Resource Groups leadership team Global Diversity and Inclusion Next Page Icon Our Commitments Global Diversity and Inclusion Report People & Business Resource Groups Learning and development programs Our Commitment to Equal Employment Opportunity Workforce statistics Giovanni Caforio reflects to Asian American hate crimes Responsibility Next Page Icon The Bristol Myers Squibb Foundation COVID-19 Updates Corporate Giving Independent medical education Supporting Our Communities Access to Medicines in the Developing World Position on Key Issues Sustainability Next Page Icon Goals & key indicators Economic responsibility Governance Social Progress Environmental performance Global Reporting Initiative Sustainability Resources Subject Index Contact Us Next Page Icon Social FEATUREDAnnual Report 2021> SearchMedicines >Careers >Press Releases >Medical Information > Global Biopharmaceutical Company - Bristol Myers Squibb Areas of focusBristol Myers Squibb is committed to discovering, developing and delivering transformational medicines in areas where we believe we have an opportunity to make a meaningful difference for patients. Learn More NEXT 2022 First Quarter Results  > Bristol Myers Squibb reports first quarter revenues of $11.6 Billion; GAAP EPS of $0.59 and non-GAAP EPS of $1.96 which include net impact of ($0.10) per share due to acquired IPRD charges partially offset by licensing income. Read more, including important cautionary statements about forward-looking information.Latest FDA Approval > Bristol Myers Squibb’s Camzyos is the first and only FDA-approved cardiac myosin inhibitor that specifically targets the source of obstructive hypertrophic cardiomyopathy (obstructive HCM)." target="_blank" class="base-anchor">Annual Report > " title="Annual Report >"/> 2021 was a year that illustrated who we are — a company focused on transforming patients’ lives through science. With our dedicated workforce, financial strength, and proven ability to execute, we will continue to advance our pipeline, contribute to our communities, and deliver sustained, long-term growth. Life & Science Stories A subset of BMS.com, Life & Science Stories is our digital magazine where we share the work our global community of colleagues are doing around the world to help patients and advance scientific innovation.Learn More >  |  Subscribe to Life & Science Stories email alerts > May 02, 2022Why is hypertrophic cardiomyopathy, the most commonly inherited heart disease, often undiagnosed?> April 21, 2022R&D facility building in the UK exemplifies sustainability innovation> April 15, 2022Consumer wearable technology advancements may support AFib detection> April 11, 2022News & PerspectivesCOLORS training program spreads education of healthcare needs in the LGBTQ+ community> April 04, 2022News & PerspectivesGive and take: The power of mentorship at Bristol Myers Squibb> April 01, 2022ScienceThe quest to stop cancer from coming back > SurvivorshipTodayEmmy winner Sterling K. Brown explores cancer survivorship during a global pandemic. Learn More> Advocating for health equity in cancer care> Transitioning from care partner to patient > Healing the mind > Moving forward.Together. Careers We’re looking for people who want to change lives.  Join us as we transform patients’ lives through science.  Learn More> Investors Learn more about how we strive to produce sustained strong performance and shareholder value. Learn More> Looking for Answers? Quick links to helpful resources. Clinical Trial Information for Researchers Clinical trials and research are a critical part of bringing new medicines to patients. Learn More> Find a Clinical Trial> Medical Information for Healthcare Providers Information and resources to assist with caring for patients. Resources for U.S. Healthcare Providers> Global Medical Information> Help Paying for Your Medicines If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help. Find Out How> Quick Links Home Patients & Caregivers Healthcare Providers Researchers Investors Careers News Resources Our Medicines Life & Science Stories About Us UK-CA Slavery and Human Trafficking Statement (PDF) Follow Us Legal Notice Privacy Policy Trademarks Forward-Looking Statement Worldwide Locations Contact Us May 02, 2022 © 2022 Bristol-Myers Squibb Company